𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma

✍ Scribed by Masaya Suzuki; Shinji Kageyama; Kazuya Shinmura; Koji Okudela; Tomoyasu Bunai; Kiyoko Nagura; Hisaki Igarashi; Shinichiro Kiyose; Hiroki Mori; Hong Tao; Masanori Goto; Kazuya Takamochi; Takahiro Mochizuki; Kazuya Suzuki; Riuko Ohashi; Hiroshi Ogawa; Takeshi Yamada; Hiroshi Niwa; Toshihiro Tsuneyoshi; Haruhiko Sugimura


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
248 KB
Volume
98
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


EGFR expression in primary squamous cell
✍ Jennifer L. Long; Ali M. Strocker; Marilene B. Wang; Keith E. Blackwell πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract We present the case of a 57‐year‐old male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely

Expression of the metastasis-associated
✍ Yasushi Toh; Takefumi Ohga; Kazuya Endo; Eisuke Adachi; Hiroki Kusumoto; Masaru πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 232 KB πŸ‘ 1 views

## Abstract Metastasis‐associated protein MTA1 and histone deacetylase form a protein complex with histone deacetylase activity that plays an important role in histone deacetylation, alteration of chromatin structure and transcriptional control. The precise role of the MTA1 protein in the malignant

Expression of p16INK4A and alterations o
✍ George Mariatos; Vassilis G. Gorgoulis; Panayotis Zacharatos; Athanassios Kotsin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 286 KB πŸ‘ 1 views

The 9p21-23 chromosome region harbors a number of known and putative tumor-suppressor genes (TSGs). The best characterized gene in this area is p16 INK4A (CDKN2A). Alterations of its product have been observed in various malignancies, including non-small-cell lung carcinomas (NSCLCs). We earlier inv